J A_16-10261_Redacted.pdf

441 KB Posted

Attached to
Research that uses amnion-derived multi-potent progenitor cells and their secreted cytokine solution to decrease loss of tissue, obtain more rapid wound closure, and decrease scarring in support of the Naval Medical Research Center, Silver Spring, MD
Solicitation number
N32398ACCS2
Issued by

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

notice of intent to award to Noveome was issued on the FBO website on 03 June 2016 and only Noveome expressed an interest in this requirement. Therefore, it is NMLC’s intention to proceed with the sole source

7. Determination of Fair and Reasonable Cost.

The Contracting Officer will perform a cost analysis in order to determine that the anticipated cost to the Government of the services covered by this Justification and Approval will be fair and reasonable.

8. Actions to Remove Barriers to Future Competition.

For the reasons set forth in Paragraph 5, NMLC has no plans at this time to compete future contracts for the type of services covered by this document. If another potential source emerges, NMLC will assess whether competition for future requirements is feasible.

File details come from the government source that posted it. Updated .